A.M. Low

447 total citations
19 papers, 374 citations indexed

About

A.M. Low is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, A.M. Low has authored 19 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in A.M. Low's work include Ion channel regulation and function (6 papers), Neuropeptides and Animal Physiology (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). A.M. Low is often cited by papers focused on Ion channel regulation and function (6 papers), Neuropeptides and Animal Physiology (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). A.M. Low collaborates with scholars based in Canada, Australia and Hong Kong. A.M. Low's co-authors include Chiu‐Yin Kwan, E. E. Daniel, Joel C. Bornstein, John B. Furness, Keith A. Sharkey, Alan Lomax, Paul Bertrand, E.E. Daniel, E. E. Daniel and C.Y. Kwan and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and Cell and Tissue Research.

In The Last Decade

A.M. Low

19 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.M. Low Canada 13 224 124 123 83 63 19 374
Zhouyi Xiong China 7 201 0.9× 102 0.8× 91 0.7× 59 0.7× 25 0.4× 13 317
Karri K. Bradley United States 8 257 1.1× 121 1.0× 87 0.7× 158 1.9× 26 0.4× 8 400
I. A. Vladimirova Ukraine 8 165 0.7× 97 0.8× 123 1.0× 27 0.3× 44 0.7× 28 328
Abigail S. Forrest United Kingdom 12 307 1.4× 131 1.1× 109 0.9× 128 1.5× 126 2.0× 17 509
N J Welsh United Kingdom 11 149 0.7× 58 0.5× 117 1.0× 58 0.7× 57 0.9× 15 357
Ann M. Sherry United States 10 385 1.7× 72 0.6× 85 0.7× 101 1.2× 148 2.3× 10 578
Charlotte Fetscher Germany 11 275 1.2× 97 0.8× 73 0.6× 28 0.3× 11 0.2× 12 584
D. Mitolo‐Chieppa Italy 11 105 0.5× 81 0.7× 106 0.9× 27 0.3× 79 1.3× 43 361
Xiao-guang Zhen United States 5 391 1.7× 101 0.8× 233 1.9× 136 1.6× 13 0.2× 9 655
Manfred Kurjak Germany 11 109 0.5× 141 1.1× 91 0.7× 24 0.3× 88 1.4× 21 462

Countries citing papers authored by A.M. Low

Since Specialization
Citations

This map shows the geographic impact of A.M. Low's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Low with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Low more than expected).

Fields of papers citing papers by A.M. Low

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Low. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Low. The network helps show where A.M. Low may publish in the future.

Co-authorship network of co-authors of A.M. Low

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Low. A scholar is included among the top collaborators of A.M. Low based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Low. A.M. Low is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Low, A.M., et al.. (1999). Insights Into the Unusual Alpha Adrenoceptor Subtype in Dog Saphenous Vein Using Phenoxybenzamine. Journal of Pharmacology and Experimental Therapeutics. 288(1). 148–156. 5 indexed citations
2.
Daniel, E. E., et al.. (1999). α-Adrenoceptors in Canine Mesenteric Artery Are Predominantly 1A Subtype: Pharmacological and Immunochemical Evidence. Journal of Pharmacology and Experimental Therapeutics. 291(2). 671–679. 6 indexed citations
3.
Lomax, Alan, Keith A. Sharkey, Paul Bertrand, et al.. (1999). Correlation of morphology, electrophysiology and chemistry of neurons in the myenteric plexus of the guinea-pig distal colon. Journal of the Autonomic Nervous System. 76(1). 45–61. 69 indexed citations
4.
Daniel, E. E., et al.. (1999). Alpha-adrenoceptors in canine mesenteric artery are predominantly 1A subtype: pharmacological and immunochemical evidence.. PubMed. 291(2). 671–9. 14 indexed citations
5.
Low, A.M., et al.. (1998). Pharmacological and Immunocytochemical Characterization of Subtypes of Alpha-1 Adrenoceptors in Dog Aorta. Journal of Pharmacology and Experimental Therapeutics. 285(2). 894–901. 11 indexed citations
6.
Low, A.M., et al.. (1997). Actions of 4‐chloro‐3‐ethyl phenol on internal Ca2+ stores in vascular smooth muscle and endothelial cells. British Journal of Pharmacology. 122(3). 504–510. 13 indexed citations
7.
Daniel, E. E., et al.. (1997). Characterization of α-Adrenoceptors in Canine Mesenteric Vein. Journal of Cardiovascular Pharmacology. 30(5). 591–598. 8 indexed citations
8.
Low, A.M.. (1996). Role of tyrosine kinase on Ca2+entry and refilling of agonist-sensitive Ca2+stores in vascular smooth muscles. Canadian Journal of Physiology and Pharmacology. 74(3). 298–304. 13 indexed citations
9.
Daniel, E. E., et al.. (1996). Unusual αadrenoceptor subtype in canine saphenous vein: comparison to mesenteric vein. British Journal of Pharmacology. 117(7). 1535–1543. 14 indexed citations
10.
Low, A.M., et al.. (1996). RELATIVE CONTRIBUTIONS OF EXTRACELLULAR Ca2+ AND Ca2+ STORES TO SMOOTH MUSCLE CONTRACTION IN ARTERIES AND ARTERIOLES OF RAT, GUINEA‐PIG DOG AND RABBIT. Clinical and Experimental Pharmacology and Physiology. 23(4). 310–316. 40 indexed citations
11.
Low, A.M.. (1996). Role of tyrosine kinase on Ca2+ entry and refilling of agonist-sensitive Ca2+ stores in vascular smooth muscles.. PubMed. 74(3). 298–304. 16 indexed citations
12.
Low, A.M., et al.. (1994). Sensitivity to protein kinase C inhibitors of nicardipine‐insensitive component of high K+contracture in rat and guinea‐pig aorta. British Journal of Pharmacology. 112(2). 604–610. 16 indexed citations
13.
Low, A.M., et al.. (1994). Interactions of chloroethylclonidine with rauwolscine‐ and prazosin‐sensitive adrenoceptors in dog saphenous vein. British Journal of Pharmacology. 113(4). 1263–1268. 13 indexed citations
14.
McConalogue, K., A.M. Low, Susan Williamson, Joel C. Bornstein, & John B. Furness. (1994). Calretinin-immunoreactive neurons and their projections in the guinea-pig colon. Cell and Tissue Research. 276(2). 359–365. 22 indexed citations
15.
Low, A.M., R. J. Lang, & E.E. Daniel. (1993). Influence of Internal Calcium Stores on Calcium-Activated Membrane Currents in Smooth Muscle. Neurosignals. 2(5). 263–271. 4 indexed citations
16.
Low, A.M., Chiu‐Yin Kwan, & E. E. Daniel. (1993). Functional Alterations in the Aorta of the Spontaneously Hypertensive Rat: Pharmacological Assessment with Cyclopiazonic Acid. Pharmacology. 47(1). 50–60. 12 indexed citations
17.
Kwan, Chiu‐Yin, et al.. (1992). Morphological and Functional Characterization of Vascular Muscle Cells Enzymatically Dispersed from Dog Mesenteric Arteries. Journal of Vascular Research. 29(6). 450–460. 3 indexed citations
18.
Low, A.M., et al.. (1991). Thapsigargin inhibits repletion of phenylephrine-sensitive intracellular Ca++ pool in vascular smooth muscles.. Journal of Pharmacology and Experimental Therapeutics. 258(3). 1105–1113. 53 indexed citations
19.
Low, A.M., et al.. (1990). Ryanodine and the adrenergic, purinergic stimulation in the rat vas deferens smooth muscle: functional and radioligand binding studies.. Journal of Pharmacology and Experimental Therapeutics. 256(3). 1063–1071. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026